CYNAPSUS THERAPEUTICS INC's ticker is CYNA and the CUSIP is 23257Y859. A total of 31 filers reported holding CYNAPSUS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,029,000 | +140.2% | 125,000 | 0.0% | 2.63% | +88.1% |
| Q2 2016 | $2,094,000 | +45.4% | 125,000 | +3.3% | 1.40% | +55.8% |
| Q1 2016 | $1,440,000 | -14.4% | 121,000 | +10.0% | 0.90% | +27.7% |
| Q4 2015 | $1,682,000 | +258.6% | 110,000 | +279.3% | 0.70% | +204.3% |
| Q3 2015 | $469,000 | – | 29,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 313,524 | $5,070,000 | 2.94% |
| Aisling Capital LLC | 975,191 | $15,769,000 | 2.77% |
| First Light Asset Management, LLC | 302,194 | $4,886,000 | 2.41% |
| PURA VIDA INVESTMENTS, LLC | 194,461 | $3,102,000 | 1.77% |
| Ghost Tree Capital, LLC | 175,000 | $2,830,000 | 1.27% |
| DAFNA Capital Management LLC | 44,824 | $707,000 | 0.70% |
| Broadfin Capital, LLC | 586,117 | $9,052,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 188,930 | $3,059,000 | 0.39% |
| Opaleye Management Inc. | 29,000 | $469,000 | 0.23% |
| J. Goldman & Co LP | 135,000 | $2,183,000 | 0.19% |